574 related articles for article (PubMed ID: 29633908)
1. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
[TBL] [Abstract][Full Text] [Related]
2. Identification of new benzamide inhibitor against α-subunit of tryptophan synthase from Mycobacterium tuberculosis through structure-based virtual screening, anti-tuberculosis activity and molecular dynamics simulations.
Naz S; Farooq U; Ali S; Sarwar R; Khan S; Abagyan R
J Biomol Struct Dyn; 2019 Mar; 37(4):1043-1053. PubMed ID: 29502488
[TBL] [Abstract][Full Text] [Related]
3. Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13.
Aggarwal A; Parai MK; Shetty N; Wallis D; Woolhiser L; Hastings C; Dutta NK; Galaviz S; Dhakal RC; Shrestha R; Wakabayashi S; Walpole C; Matthews D; Floyd D; Scullion P; Riley J; Epemolu O; Norval S; Snavely T; Robertson GT; Rubin EJ; Ioerger TR; Sirgel FA; van der Merwe R; van Helden PD; Keller P; Böttger EC; Karakousis PC; Lenaerts AJ; Sacchettini JC
Cell; 2017 Jul; 170(2):249-259.e25. PubMed ID: 28669536
[TBL] [Abstract][Full Text] [Related]
4. Computational characteristics of the structure-activity relationship of inhibitors targeting Pks13-TE domain.
Wang S; Luan J; Chen L; Liu H; Li W; Wang J
Comput Biol Chem; 2023 Jun; 104():107864. PubMed ID: 37028177
[TBL] [Abstract][Full Text] [Related]
5. Insights into an alternative benzofuran binding mode and novel scaffolds of polyketide synthase 13 inhibitors.
Çınaroğlu SS; Timuçin E
J Mol Model; 2019 Apr; 25(5):130. PubMed ID: 31025202
[TBL] [Abstract][Full Text] [Related]
6. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
[TBL] [Abstract][Full Text] [Related]
7. Optimization of TAM16, a Benzofuran That Inhibits the Thioesterase Activity of Pks13; Evaluation toward a Preclinical Candidate for a Novel Antituberculosis Clinical Target.
Wilson C; Ray P; Zuccotto F; Hernandez J; Aggarwal A; Mackenzie C; Caldwell N; Taylor M; Huggett M; Mathieson M; Murugesan D; Smith A; Davis S; Cocco M; Parai MK; Acharya A; Tamaki F; Scullion P; Epemolu O; Riley J; Stojanovski L; Lopez-Román EM; Torres-Gómez PA; Toledo AM; Guijarro-Lopez L; Camino I; Engelhart CA; Schnappinger D; Massoudi LM; Lenaerts A; Robertson GT; Walpole C; Matthews D; Floyd D; Sacchettini JC; Read KD; Encinas L; Bates RH; Green SR; Wyatt PG
J Med Chem; 2022 Jan; 65(1):409-423. PubMed ID: 34910486
[TBL] [Abstract][Full Text] [Related]
8. Ursolic acid as a potential inhibitor of Mycobacterium tuberculosis cytochrome bc1 oxidase-a molecular modelling perspective.
Tembe N; Machaba KE; Ndagi U; Kumalo HM; Mhlongo NN
J Mol Model; 2022 Jan; 28(2):35. PubMed ID: 35022913
[TBL] [Abstract][Full Text] [Related]
9. Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches.
Ramasubban G; Therese KL; Vetrivel U; Sivashanmugam M; Rajan P; Sridhar R; Madhavan HN; Meenakshi N
Int J Antimicrob Agents; 2011 Apr; 37(4):368-72. PubMed ID: 21330112
[TBL] [Abstract][Full Text] [Related]
10. Computational study of the binding mechanism between farnesoid X receptor α and antagonist N-benzyl-N-(3-(tertbutyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) benzamide.
Du J; Qiu M; Guo L; Yao X
J Biomol Struct Dyn; 2019 Apr; 37(6):1628-1640. PubMed ID: 29633919
[TBL] [Abstract][Full Text] [Related]
11. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads.
Wang X; Zhao W; Wang B; Ding W; Guo H; Zhao H; Meng J; Liu S; Lu Y; Liu Y; Zhang D
Bioorg Chem; 2021 Sep; 114():105110. PubMed ID: 34175719
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Zhang W; Liu LL; Lun S; Wang SS; Xiao S; Gunosewoyo H; Yang F; Tang J; Bishai WR; Yu LF
Eur J Med Chem; 2021 Mar; 213():113202. PubMed ID: 33516983
[TBL] [Abstract][Full Text] [Related]
13. An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis.
Altharawi A; Alossaimi MA; Alanazi MM; Alqahatani SM; Tahir Ul Qamar M
Sci Rep; 2023 Apr; 13(1):7014. PubMed ID: 37117557
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation.
Fang J; Wu P; Yang R; Gao L; Li C; Wang D; Wu S; Liu AL; Du GH
Acta Pharm Sin B; 2014 Dec; 4(6):430-7. PubMed ID: 26579414
[TBL] [Abstract][Full Text] [Related]
15. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
16. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae.
Kaur G; Pandey B; Kumar A; Garewal N; Grover A; Kaur J
J Biomol Struct Dyn; 2019 Mar; 37(5):1254-1269. PubMed ID: 29557724
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel hit molecules targeting M. tuberculosis polyketide synthase 13 by combining generative AI and physics-based methods.
Chikhale RV; Choudhary R; Malhotra J; Eldesoky GE; Mangal P; Patil PC
Comput Biol Med; 2024 Jun; 176():108573. PubMed ID: 38723396
[TBL] [Abstract][Full Text] [Related]
18. An Investigation of Molecular Docking and Molecular Dynamic Simulation on Imidazopyridines as B-Raf Kinase Inhibitors.
Xie H; Li Y; Yu F; Xie X; Qiu K; Fu J
Int J Mol Sci; 2015 Nov; 16(11):27350-61. PubMed ID: 26580609
[TBL] [Abstract][Full Text] [Related]
19. Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Zhang W; Lun S; Liu LL; Xiao S; Duan G; Gunosewoyo H; Yang F; Tang J; Bishai WR; Yu LF
J Med Chem; 2019 Apr; 62(7):3575-3589. PubMed ID: 30875203
[TBL] [Abstract][Full Text] [Related]
20. Identification and Optimization of Novel Inhibitors of the Polyketide Synthase 13 Thioesterase Domain with Antitubercular Activity.
Green SR; Wilson C; Eadsforth TC; Punekar AS; Tamaki FK; Wood G; Caldwell N; Forte B; Norcross NR; Kiczun M; Post JM; Lopez-Román EM; Engelhart CA; Lukac I; Zuccotto F; Epemolu O; Boshoff HIM; Schnappinger D; Walpole C; Gilbert IH; Read KD; Wyatt PG; Baragaña B
J Med Chem; 2023 Nov; 66(22):15380-15408. PubMed ID: 37948640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
